EBITDA Growth
-30.40%
Quarterly · Period ending:
HCAT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.40%period ending
Latest reported-30.40%period ending
HCAT Quarterly EBITDA YoY % (-0.19% → -30.40%)
Year-over-year change
High-resolution chart · PNG
HCAT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -30.3978% | |
| -2,309.5348% | |
| -2,807.3239% | |
| 41.4884% | |
| -2,248.2723% | |
| 52.0813% | |
| 86.2243% | |
| 32.4096% | |
| 95.2183% | |
| 60.0197% | |
| 18.9076% | |
| 68.2762% | |
| -0.1053% | |
| -61.7682% | |
| 33.9225% | |
| 0.5133% | |
| 15.886% | |
| 23.0934% | |
| -13.7831% | |
| -74.1227% | |
| -16.4066% | |
| -14.6016% | |
| -191.0674% | |
| -3.9578% | |
| -202.6738% | |
| -40.3448% | |
| 5.6437% | |
| -21.5421% | |
| 60.7692% | |
| -0.1875% |